Interventional Therapies Articles & Analysis: Older
7 news found
Idiopathic pulmonary fibrosis (IPF) remains a devastating condition with limited treatment options, often leading to a grim prognosis. However, a recent study by Milman-Krentsis (2024) offers a beacon of hope, demonstrating the potential of lung cell transplantation as a therapeutic intervention for lung fibrosis. Utilizing two distinct mouse models—one treated with bleomycin and another ...
Vascular embolization, performed by interventional radiologists, is an effective therapy for addressing the symptoms of patients suffering from this condition. ...
“Continuous IOP monitoring represents the beginning of a paradigm shift towards evidence-based diagnostics for healthcare providers and payors who will see the economic value of earlier intervention in slowing vision loss and improving quality of life,” said Ariel Cao, president and CEO, Injectsense Inc. ...
” InspireMD CEO, Marvin Slosman, added, “This milestone marks the beginning of what we consider to be the next step in our journey of establishing CGuard EPS as the leading stent device for treatment of CAD and the transition from surgical intervention to endovascular therapy. The U.S. market has been a priority for our company and we believe that ...
“The highest bar is needed to validate closed-loop SCS therapies, and I applaud the scientists and clinician researchers who have dedicated themselves to the advancement of new neuromodulation therapies in pain ...
” Solbiati added, “Histotripsy’s non-invasive approach and novel mechanical destruction of tumors provide potential for this procedure to become a leading technology in interventional therapies.” Joe Amaral, MD, HistoSonics’ Vice President of Medical Affairs, also commented, “I am excited to work with our co-Principal ...
Leon, MD, professor of medicine and Director of the Center for Interventional Vascular Therapy at Columbia University Irving Medical Center and NewYorkPresbyterian, and chairman of the CorCinch-HF study. “The CorCinch clinical programs are developing a new class of therapy and the clinical trials have embraced a strong collaboration between ...